Profile
Xcellerant Ventures is a venture capital firm based in Scottsdale, Arizona, founded in 2021 by John Shufeldt, Douglas Sylvester, and Chris Yoo. The firm specializes in healthcare investments, focusing on healthtech and medtech sectors. With a team of nine professionals, Xcellerant Ventures aims to empower entrepreneurs by providing hands-on advice and support, leveraging the founders' extensive experience in medical technologies, law, and entrepreneurship.
The firm primarily invests in early-stage companies that are developing innovative solutions to improve healthcare quality, efficiency, and accessibility. Xcellerant Ventures typically provides early-stage funding, with a focus on companies that have cleared regulatory hurdles and are on a rapid path to financial growth. The firm manages the Xcellerant Venture Capital Fund I, launched in 2023 with $7 million in assets under management, and the Jetstream Venture Fund, which targets high-growth technology and healthcare companies.
Notable investments by Xcellerant Ventures include Carbogenesis - industrial chemicals, Mindset Medical - healthcare technology systems, DeepLook Medical - decision/risk analysis, CRISPR QC - healthcare technology systems, and SimBioSys - decision/risk analysis.
Industry
Xcellerant Ventures Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Xcellerant Venture Capital Fund I
|
Venture Capital (VC)
|
Biotechnology
Healthcare Services
MedTech
Life Sciences
Infrastructure
HealthTech
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$7 M
|
January 2023
|
|
Jetstream Venture Fund
|
Venture Capital (VC)
|
Aerospace
Biotechnology
MedTech
CleanTech
HealthTech
|
Seed
|
Europe
|
$1-5 m
|
—
|
March 2026
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.